Leo International Precision Health Aktiengesellschaft

As of June 30, 2025, Leo International Precision Health Aktiengesellschaft carries a market capitalization of 27,025.00, placing it among publicly traded companies globally. Its enterprise value stands at 7,476.42, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2025, Leo International Precision Health Aktiengesellschaft has 500,000.00 shares outstanding.

As of June 30, 2025, Leo International Precision Health Aktiengesellschaft maintains a current ratio of 0.07, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities.

As of the close on October 22, 2026, Leo International Precision Health Aktiengesellschaft's stock has gained approximately 52.64% over the past 52 weeks. The 50-day moving average sits at 0.08, while the 200-day moving average is 0.10.

These figures are as of June 30, 2025. Total book value stands at - -, with working capital of -251,430.73 providing operational flexibility.

Leo International Precision Health Aktiengesellschaft's most recent stock split took place on October 12, 2026 with a 72:13321 split ratio.